# Nitric Oxide in Cardiopulmonary Bypass for Renal Protection in Cardiac Surgery

> **NCT03527381** · PHASE1,PHASE2 · COMPLETED · sponsor: **Nikolay Kamenshchikov** · enrollment: 96 (actual)

## Conditions studied

- Coronary Artery Disease
- Heart Valve Diseases
- Cardiomyopathies
- Acute Kidney Injury

## Interventions

- **DRUG:** Nitric Oxide
- **OTHER:** Standard CPB

## Key facts

- **NCT ID:** NCT03527381
- **Lead sponsor:** Nikolay Kamenshchikov
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09-01
- **Primary completion:** 2016-12-25
- **Final completion:** 2017-04-14
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2020-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03527381

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03527381, "Nitric Oxide in Cardiopulmonary Bypass for Renal Protection in Cardiac Surgery". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03527381. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*